Moderna’s recent decision to pause its mRNA RSV vaccine trial for children raises critical safety concerns. Explore the implications of this development and potential risks associated with mRNA technology.
Moderna’s recent decision to pause its mRNA RSV vaccine trial for children raises critical safety concerns. Explore the implications of this development and potential risks associated with mRNA technology.